Predicting disease progression in cystic fibrosis

Expert Review of Respiratory Medicine
Oded BreuerLidija Turkovic

Abstract

Progressive lung disease is the major cause of morbidity and mortality in patients with cystic fibrosis (CF). Methods of correctly predicting the future progression of lung disease in patients with CF are essential for directing aggressive treatment to prevent loss of lung function and end stage respiratory failure. Areas covered: This review addresses predictors of respiratory disease progression in patients with CF. We searched Web of Science and Medline, with no restriction on publication date, with the search terms 'cystic fibrosis' and 'disease progression', 'lung function decline', 'prognosis', 'prediction/predictive', 'prediction/prognostic scores', 'risk factors', 'outcome measures/endpoints/disease surrogate', 'longitudinal/long term', 'statistical model', and 'survival'. Expert commentary: Forced expiratory volume in 1 sec (FEV1) and rate of FEV1 decline, remain the most significant predictors of mortality in patients with CF while CT scores and airway secretion biomarkers are the main predictors of early CF lung disease. Comprehensive scores incorporating clinical, lung function, imaging and laboratory data will become essential in the future for predicting disease progression and for use in clinical trials. Early in...Continue Reading

References

Apr 30, 1992·The New England Journal of Medicine·E KeremH Levison
Mar 1, 1973·The Journal of Pediatrics·L M TaussigP A Di Sant'Agnese
May 15, 1996·American Journal of Epidemiology·M Corey, V Farewell
May 1, 1997·American Journal of Epidemiology·M RosenfeldB Ramsey
Sep 16, 2000·American Journal of Respiratory and Critical Care Medicine·C E MillaA Moran
Feb 24, 2001·American Journal of Epidemiology·T G LiouB C Marshall
Apr 6, 2002·American Journal of Respiratory and Critical Care Medicine·Carolyn J DakinRichard L Henry
Aug 31, 2002·Pediatric Pulmonology·Harm A W M Tiddens
Oct 31, 2002·American Journal of Respiratory and Critical Care Medicine·Nicole Mayer-HamblettMoira L Aitken
Nov 16, 2002·American Journal of Respiratory and Critical Care Medicine·Kenneth N OlivierUNKNOWN Nontuberculous Mycobacteria in Cystic Fibrosis Study Group
Jul 1, 1958·A.M.A. Journal of Diseases of Children·H SHWACHMAN, L L KULCZYCKI
Jan 24, 2004·The European Respiratory Journal·P A de JongH A W M Tiddens
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·J M CourtneyJ S Elborn
Nov 9, 2004·American Journal of Respiratory and Critical Care Medicine·Richard KraemerSabina Gallati
Feb 3, 2005·JAMA : the Journal of the American Medical Association·Zhanhai LiMark L Splaingard
Aug 16, 2005·American Journal of Respiratory and Critical Care Medicine·Alan S BrodyUNKNOWN CT Scanning in Cystic Fibrosis Special Interest Group
Aug 16, 2005·American Journal of Respiratory and Critical Care Medicine·Alan S BrodyJoanne Quan
Mar 18, 2006·American Journal of Respiratory and Critical Care Medicine·Delphine L ChenDaniel P Schuster
Jul 22, 2006·American Journal of Respiratory and Critical Care Medicine·Mark D SchluchterMichael R Knowles
Nov 14, 2006·Chest·Edward F McKoneMoira L Aitken
Jan 20, 2007·American Journal of Respiratory and Critical Care Medicine·Nicole Mayer-HamblettBonnie W Ramsey
May 1, 2007·Pediatric Pulmonology·J M CourtneyJ S Elborn
Jul 24, 2007·The Journal of Pediatrics·Michael W KonstanUNKNOWN Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis
May 8, 2009·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·R BuzzettiG Mastella
May 23, 2009·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Michael W KonstanDonald R VanDevanter
Aug 19, 2010·Pediatric Pulmonology·Donald R VanDevanterMichael W Konstan
Oct 12, 2010·American Journal of Respiratory and Critical Care Medicine·Paul AuroraUNKNOWN London Cystic Fibrosis Collaboration
Mar 15, 2011·Thorax·Sarath C RanganathanUNKNOWN Australian Respiratory Early Surveillance Team for Cystic Fibrosis
Mar 23, 2011·Thorax·C M OwensUNKNOWN London Cystic Fibrosis Collaboration

❮ Previous
Next ❯

Citations

Oct 2, 2021·Pediatric Pulmonology·Daan CaudriUNKNOWN AREST CF Study Group
Sep 13, 2020·Paediatric Respiratory Reviews·Jagdev SinghDominic A Fitzgerald
Dec 31, 2021·Pediatric Pulmonology·Aarti ShakkottaiRonald D Chervin
Feb 3, 2022·Microbiology Spectrum·Jamie C HarrisThomas S Murray

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Pediatric Pulmonology
Michael W KonstanScientific Advisory Group and Investigators and Coordinators of Epidemiologic Study of Cystic Fibrosis
The Journal of Pediatrics
Michael W KonstanScientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis
© 2022 Meta ULC. All rights reserved